Search

Search Constraints

You searched for: Author/Creator Braylan, Raul

Search Results

1. Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma. (10th March 2021)

2. Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma. (10th March 2021)

3. Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation. Issue 4 (2nd February 2021)

4. Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma. Issue 1 (2nd January 2018)

5. Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method. Issue 5 (May 2015)

6. Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma. Issue 6 (June 2014)

7. Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study. Issue 10 (October 2013)